Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-01 6:34 pm Purchase | 13G | NEXTCURE INC NXTC | Logos Global Management LP | 2,000,460 7.2% | 2,000,460 (New Position) | View |
| 2024-02-22 3:47 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Logos Global Management LP | 15,000,000 7.2% | 15,000,000 (New Position) | View |
| 2024-02-14 4:01 pm Sale | 13G | ALLAKOS INC ALLK | Logos Global Management LP | 2,900,000 3.3% | -2,386,666 (-45.15%) | View |
| 2024-02-14 3:51 pm Purchase | 13G | SPYRE THERAPEUTICS, INC SYRE | Logos Global Management LP | 150,000 0.4% | 150,000 (New Position) | View |
| 2024-02-13 7:31 pm Sale | 13G | IDEAYA BIOSCIENCES INC IDYA | Logos Global Management LP | 1,800,000 2.8% | -2,100,000 (-53.85%) | View |
| 2024-02-13 7:23 pm Purchase | 13G | ANNEXON INC ANNX | Logos Global Management LP | 6,944,444 8.3% | 3,844,444 (+124.01%) | View |
| 2024-01-22 4:57 pm Purchase | 13G | ELEVATION ONCOLOGY INC ELEV | Logos Global Management LP | 3,650,000 8.6% | 3,650,000 (New Position) | View |
| 2024-01-22 4:27 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Logos Global Management LP | 3,469,927 9.9% | 3,469,927 (New Position) | View |
| 2024-01-02 12:21 pm Purchase | 13G | ATYR PHARMA INC LIFE | Logos Global Management LP | 5,800,000 9.9% | 5,800,000 (New Position) | View |
| 2023-11-27 5:39 pm Purchase | 13D | OLEMA PHARMACEUTICALS INC OLMA | Logos Global Management LP | 4,266,948 7.8% | 508,130 (+13.52%) | View |
| 2023-07-18 4:01 pm Purchase | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Logos Global Management LP | 6,350,000 8.1% | 6,350,000 (New Position) | View |
| 2023-06-22 1:25 pm Purchase | 13G | ANNEXON INC ANNX | Logos Global Management LP | 3,100,000 5.8% | 3,100,000 (New Position) | View |
| 2023-02-14 4:23 pm Sale | 13G | ALLAKOS INC ALLK | Logos Global Management LP | 5,286,666 6.2% | -650,000 (-10.95%) | View |
| 2023-02-14 4:14 pm Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | Logos Global Management LP | 3,900,000 8.1% | 3,900,000 (New Position) | View |
| 2023-02-14 4:07 pm Sale | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Logos Global Management LP | 1,435,000 4.8% | -115,000 (-7.42%) | View |
| 2023-02-14 3:53 pm Sale | 13G | DYNE THERAPEUTICS INC DYN | Logos Global Management LP | 2,150,000 4.1% | -804,392 (-27.23%) | View |
| 2022-09-28 5:30 pm Purchase | 13G | ALLAKOS INC ALLK | Logos Global Management LP | 5,936,666 7% | 5,936,666 (New Position) | View |
| 2022-05-02 4:02 pm Purchase | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Logos Global Management LP | 1,550,000 5.2% | 680,000 (+78.16%) | View |
| 2022-03-31 4:23 pm Purchase | 13D | DESIGN THERAPEUTICS INC DSGN | Logos Global Management LP | 2,812,501 5% | 2,812,501 (New Position) | View |
| 2022-03-18 5:04 pm Purchase | 13G | HARPOON THERAPEUTICS INC HARP | Logos Global Management LP | 2,650,000 6.9% | 1,150,000 (+76.67%) | View |